| abstract |
ADMINISTRATION TO THE TISSUE FACTOR STEP INHIBITOR AIR CONDITIONS, IN INFLAMMATORY CONDITIONS THAT AFFECT THE RESPIRATORY TRACT. The present invention provides methods for the local treatment of acute and chronic extravascular pulmonary fibrin deposition and / or reduction of unwanted effects associated with the systemic administration of natural anticoagulants to an individual, by administration to the individual's respiratory airways, for example. intratracheal, intrabronchial or intra-alveolar route of natural anticoagulants or their biologically active derivatives. |